Lymphoma Action
Non-Profit & Charitable Organizations · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Bell Business Park Smeaton Close Unit 3,...Phone Number
+44 1296619400Website
www.lymphoma-action.org.ukRevenue
<$5 MillionIndustry
About Lymphoma Action
Is Lymphoma Action your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Lymphoma Action has new funding data
Product Launch: Get notified when Lymphoma Action launches new products
Congratulate Masked Content for being promoted to Masked Content at Lymphoma Action
Check out if Lymphoma Action is spiking on competitors!
Earning: See what the market has to say on Lymphoma Action recently announced quarterly report
Check if Lymphoma Action has recently received funding, and reach out quickly before it becomes old news!
Click to see if Lymphoma Action had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Lymphoma Action, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Lymphoma Action
Compare insights from companies similar to Lymphoma Action, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Lymphoma Action
Company Profile Activity
Activity Insights
Lymphoma Action is experiencing very low activity levels compared to other companies in the Organizations sector.
What does this means?
Lymphoma Action is drawing exceptional interest within the Organizations industry, suggesting notable developments or strong market momentum, learn more about Lymphoma Action.
Lymphoma Action Tech Stack
A closer look at the technologies used by Lymphoma Action
Most Recent Scoops
Lymphoma Action News & Media
Kyowa Kirin welcomes the decision that NICE will revisit their appraisal of the innovative systemic treatment, POTELIGEO®▼ (mogamulizumab), for adults living with two forms of ultra-rare non-Hodgkin lymphoma
LONDON--(BUSINESS WIRE)--The National Institute for Health and Care Excellence (NICE) has upheld an appeal lodged by Kyowa Kirin, Lymphoma Action and Leukaemia Care, and the UK Cutaneous Lymphoma Group (UKCLG) as part of the Single Technology Appraisal for POTELIGEO® (mogamulizumab) for the treatment of adults with the ultra-rare blood cancers mycosis fungoides (MF) or Sézary syndrome (SS) who have received at least one prior systemic therapy.1 The oral appeal hearing took place on 10 May
Top Non-Profit & Charitable Organizations Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Lymphoma Action
Lymphoma Action is the UK's only charity dedicated to supporting individuals affected by lymphoma, the fifth most common cancer. With over 30 years of experience, the organization provides expert information, resources, and emotional support to patients, their families, and healthcare professionals. They offer a range of services including helpline... Read More